Association between coffee consumption and risk of recurrent venous thromboembolism – Results from the Trøndelag Health Study and Tromsø Study
Research and Practice in Thrombosis and Haemostasis · 2026-10 · 10 (7) · 106966
DOI: 10.1016/j.rpth.2026.106966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2026-10. Verfasst von Melliane M Olsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nord-Trøndelag Hospital Trust, Norway. Hauptthemen laut MEDLINE: Coffee, Venous Thromboembolism. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Epidemiological studies have shown that coffee consumption is associated with a lowered risk of incident venous thromboembolism (VTE). No previous study has explored whether coffee consumption influences the risk of VTE recurrence.
Objectives
This study aimed to investigate whether the amount of coffee consumption (cups/d) is associated with the risk of VTE recurrence in a population-based cohort of incident VTEs.
Methods
The cohort consisted of 2071 patients with incident VTE recruited from 4 surveys of the Tromsø Study (enrolment, 1994-2008) and the third survey of the Trøndelag Health Study (enrolment, 2006-2008), followed from the date of the index VTE until 2020. Information on coffee consumption (cups/d) and potential confounders was extracted. Cox regression models were used to estimate hazard ratios (HRs) with 95% CIs for VTE recurrence.
Results
During a median follow-up of 2.8 years, 310 recurrent VTEs occurred. There was no linear relationship between increasing coffee intake and VTE recurrence. The HR for recurrence was 0.49 (95% CI, 0.30-0.81) for those consuming 1 to 2 cups of coffee per day and 0.71 (95% CI, 0.44-1.12) for those consuming >6 cups compared with noncoffee consumers. The association between coffee consumption (yes/no) and lowered recurrence risk was more pronounced for provoked index VTE event (HR, 0.50; 95% CI, 0.30-0.82) than for unprovoked index VTE (HR, 1.01; 95% CI, 0.53-1.94).
Conclusion
Coffee consumption was associated with a nonlinear, lowered risk of VTE recurrence, particularly after provoked VTE. Our findings suggest that coffee can be safely consumed after VTE, potentially with a beneficial effect on recurrence risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nord-Trøndelag Hospital Trust, Norway.
- Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
- Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
- HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway.
- Department of Public Health and Nursing, HUNT Research Center, Norwegian University of Science and Technology, Levanger, Norway.
- Department of Research, St. Olav University Hospital, Trondheim, Norway.
Zitieren
APA
Olsen, M. M., Brækkan, S. K., Hveem, K., Grønning, K., & Hansen, J. B. (2026). Association between coffee consumption and risk of recurrent venous thromboembolism – Results from the Trøndelag Health Study and Tromsø Study. Research and Practice in Thrombosis and Haemostasis, 10(7), 106966. https://doi.org/10.1016/j.rpth.2026.106966
Vancouver
Olsen MM, Brækkan SK, Hveem K, Grønning K, Hansen JB. Association between coffee consumption and risk of recurrent venous thromboembolism – Results from the Trøndelag Health Study and Tromsø Study. Research and Practice in Thrombosis and Haemostasis. 2026;10(7):106966. doi:10.1016/j.rpth.2026.106966
BibTeX
@article{Olsen2026,
author = {Olsen, Melliane M and Brækkan, Sigrid K and Hveem, Kristian and Grønning, Kjersti and Hansen, John-Bjarne},
title = {Association between coffee consumption and risk of recurrent venous thromboembolism – Results from the Trøndelag Health Study and Tromsø Study},
journal = {Research and Practice in Thrombosis and Haemostasis},
year = {2026},
volume = {10},
number = {7},
pages = {106966},
doi = {10.1016/j.rpth.2026.106966}
}
EUVIMED